Home > Healthcare > Medical Services > Inpatient and Outpatient Services > U.S. Ambulatory Surgical Centers Market
U.S. Ambulatory Surgical Centers Market size was valued at more than USD 36 billion in 2022 and is expected to depict over 3.5% CAGR from 2023 to 2032.
The rising geriatric population has increased the prevalence of chronic disorders. According to the Centers for Disease Control and Prevention (CDC), 6 in 10 adults in the United States have an acute disorder. The geriatric population is more vulnerable to acute disorders and other ailments owing to weaken immunity. Therefore, the high occurrence of acute disorders along with the growing elderly population will fuel the development of treatment facilities such as ambulatory surgical centers.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
U.S. Ambulatory Surgical Centers Market Size in 2022: | 36 Billion (USD) |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 3.5% |
2032 Value Projection: | 54 Billion (USD) |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 103 |
Tables, Charts & Figures: | 71 |
Segments covered: | Ownership, Surgery type, Specialty type, Service |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
High costs of surgical procedures such as interventional cardiology services, neurosurgery, cardiovascular, and orthopedic surgeries may inhibit the market progression. Digital X-ray units, particularly those that are portable, can cost more than USD 100,000 in the United States. Additionally, the high costs associated with device availability may market development in the United States.
U.S. ambulatory surgical centers market value from the hospital-only ownership segment is anticipated to register more than 3.5% CAGR from 2023 to 2032. This can be credited to the rapid technological advancements in hospital infrastructure. Hospital settings also employ skilled doctors that can perform minimally invasive surgical procedures. This enables healthcare professionals to conduct these procedures in hospital-owned ASCs. The provision of these benefits, along with supportive financial assistance will accelerate the development of hospital-owned ambulatory surgical centers in the U.S. over the forecast period.
U.S. ambulatory surgical centers market from the otolaryngology surgery segment is anticipated to depict over 1% CAGR from 2023 to 2032. Growing noise pollution has increased the prevalence of hearing loss disorders in the Unties States. One in five teenagers in the U.S. witness some form of hearing impairment due to loud noises. The rising occurrence of ENT disorders has increased the adoption of otolaryngology surgical procedures. Furthermore, the availability of affordable and effective technologies for the diagnosis and treatment of hearing impairment will promote the use of ASCs for otolaryngology procedures in the U.S.
The multi-specialty segment accounted for over 40.5% share of the U.S. ambulatory surgical centers market in 2022. This is accredited to the wide range of services provided by multi-specialty ambulatory surgical centers, enabling the expansion of revenue across the establishment. Additionally, rising administrative support to promote advanced healthcare infrastructure will enable the integration of multi-specialty ambulatory surgical centers in the United States.
U.S. ambulatory surgical centers market from the treatment service segment is projected to register more than 3.5% CAGR between 2023 to 2032. This can be attributed to the growing occurrence of acute conditions such as cancer and cardiovascular disorders across the United States. Ambulatory surgical centers provide an affordable treatment alternative in comparison to other healthcare organizations such as hospitals. With the increasing diagnosis of chronic disorders, the expansion of treatment services in ASCs in the United States will grow at a steady pace.
Some of the companies operating in the U.S. ambulatory surgical centers market include :Ambulatory Surgical Center of America, :
Many of these companies are involved in partnerships that enable their business expansion and strengthen their market position.
For instance, in May 2022, Surgery Partners and ValueHealth announced a partnership, aimed at bringing the two companies together to develop upcoming de novo ASCs to cater to the growing demand for surgical care.
The COVID-19 pandemic had a severe impact on the daily operations of ASCs during the year 2020. Following the guideline issued by the Ambulatory Surgery Center Association (ASCA), selective surgical procedures were delayed until the crisis passed. For instance, the CMS (Centers for Medicare & Medicaid Services) declared all non-essential dental and medical procedures and all elective surgeries to be kept on hold during the initial months of the pandemic. This may have had an adverse impact on the U.S. ambulatory surgical centers industry trends at the peak of the outbreak. However, with the gradual resumption of elective procedures, there will be a significant increase in the exodus of procedures from hospitals to ambulatory surgical centers across the United States, creating favorable opportunities for market share.
Click here to Buy Section of this Report
By Ownership
By Surgery Type
By Specialty Type
By Service